Medical Cannabis Market 2019 Forecast Outlook by Pharmaceutical Companies, Medical Applications, Cannabinoids Product, Cannabis Revenue Growth & Regional Landscape

Medical Cannabis industry is still in its nascent stage & will develop significantly in the coming years. Increasing use of marijuana in therapeutic applications such as pain management in neurology, cancer, HIV/AIDS, seizures, & nausea will drive the medical cannabis market growth

Dallas, United States - August 14, 2019 /MarketersMedia/ —

The research report on ‘global medical cannabis market’ provides a detailed market analysis with market share and major players operating in the market. The report also covers the comprehensive outlook of technology, product specification, production analysis, and product type with the help of some key factors such as gross margin, cost, and revenue. The global medical cannabis market report offers in-depth study market segmentation depending on several regions. The report also contains the qualitative and quantitative analysis of market players.

Get Research Insights @ Global Medical Cannabis Market Research Report

Global medical cannabis market size is valued at US$ 7.26 billion from US$ 56.70 billion at a recorded CAGR of 29.3% over the forecast period. Increasing countries approving the utilization of cannabis, increasing edible products, and rising Research & Development activities are fueling the global medical cannabis market growth. In addition, rising growth of therapies with cannabis expected to drive the global medical cannabis market growth.

The global medical cannabis market segmentation is done with the help of indication and geographical regions. By indication, the global medical cannabis market is divided into neurological disease, pain management, and many others. However, the pain management segment is accounted for the highest global medical cannabis market share of 60%, and it is likely to dominate its growth over the forecast period. Many patients with lasting disorders need medical cannabis and it is anticipated to boost the global medical cannabis market growth during the prediction period. Likewise, medical cannabis shows positive results in number of chronic diseases such as Alzheimer’s, Parkinson’s, and Epilepsy.

Medical Cannabis Market Size by Indication (Pain Management, Neurological disorders, and others) by Region and Forecast 2016 to 2026 @ https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Based on regional landscape, the global medical cannabis market is sub-segmented into the North America, Asia Pacific, Europe, MEA, and Central & South America. In between these, the North America region dominated for the highest global medical cannabis market share over the forecast period. However, Canada and United States are major regions which authorized medical cannabis with maximum number of consumers. Increased awareness about medical usage and its benefits in chronic disease are projected to rise rapidly than the North American market.

North America dominates the global medical cannabis market by contributing over 90% of total revenue, of which majority comes from the U.S. Additionally, legalization in Canada is expected to grow at a faster CAGR compared to the U.S., on account of growth phase of Canadian market. The total number of patients using medical cannabis in Canada has increased in the past few quarters with corresponding increase in the number of licensed producers. This increase in number of medical cannabis users has led to a spike in revenues for companies. Such prevailing dynamics in the Canadian market is expected to attract investors in the coming years.

The global medical cannabis market is highly competitive owing to the large number of leading competitors playing in the market. These players are trying to stand their position in the global as well as local market. They use several strategies such as merger & acquisition, new product launches, and R&D activities. Some top players operating in this market are Maricann Group, Inc., Aphria, Inc., ABcann Medicinals, GW Pharmaceuticals, Organigram Holding, Inc., and Lexaria Corp.

Make an Enquire to Buy This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/864

Key Segments of the Global Medical Cannabis Market

Indication Overview, 2016-2026 (USD Billion)
• Pain Management
• Neurological Disease
• Others

Regional Overview, 2015-2025 (USD Million)
• North America
• U.S.
• Canada
• Europe
• Germany
• Spain
• Italy
• Asia Pacific
• Australia
• New Zealand
• Central & South America
• Mexico
• Uruguay
• Middle East & Africa

Buy the report @ https://www.adroitmarketresearch.com/researchreport/purchase/864

Major points from Table of Contents:

Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Medical cannabis Market Overview, By Indication
Chapter 5. Key Country Market
Chapter 6. Company Profiles

Grasp advance knowledge on Global Medical Cannabis Industry through in-depth Blogs, White Paper & Infographics:

Access the Blog: “Medical Cannabis Helpful For Insomnia Patients

Across North America sleep disorders are very common now. Actually, many of the approximations are suggesting one in four Canadians suffering from insomnia, making it a common disorder of sleep.

Access the White Paper “All You Need To Know About Medical Cannabis

Recent United States Cannabis Research and Policy & Law Cannabis has validated health benefits since past few years. However, less than 6% of current studies on marijuana investigate its medical properties, periodicals to date specify that cannabis shows promise for the treatment of several diseases and symptoms. Though, patients with cancer and chronic pain, for ex. have been blocked from such benefits since the mid-20th century when government regulations were sanctioned that banned the sales, use, and distribution of cannabis due to its psychoactive properties.

About Adroit Market Research:

Adroit Market Research provide quantified B2B research on numerous opportunistic markets, and offer customized research reports, consulting services, and syndicate research reports. We assist our clients to strategize business decisions and attain sustainable growth in their respective domain. Additionally, we support them with their revenue planning, marketing strategies, and assist them to make decisions before the competition so that they remain ahead of the curve.

Contact Info:
Name: Ryan Johnson
Email: Send Email
Organization: Adroit Market Research
Address: 3131 McKinney Ave Ste 600 Dallas, TX 75204, U.S.A
Phone: +1 972-362 -8199
Website: https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Source URL: https://marketersmedia.com/medical-cannabis-market-2019-forecast-outlook-by-pharmaceutical-companies-medical-applications-cannabinoids-product-cannabis-revenue-growth-regional-landscape/88907320

Source: MarketersMedia

Release ID: 88907320

Latest News

With eyes on election, White House insists economy is strong

Aug 20, 2019

WASHINGTON — The "fundamentals" of the U.S. economy are solid, the White House asserted on Monday, invoking an ill-fated political declaration of a decade ago amid mounting concern that a recession could imperil President Donald Trump's reelection. Exhibiting no such concern, senior adviser Kellyanne Conway declared to reporters, "The fact is, the fundamentals of our economy are very strong," It's a phrase with a history. Republican John McCain was accused of being out of touch when he made a similar declaration during the 2008 presidential campaign just hours before investment bank Lehman Brothers filed for bankruptcy, setting off a stock...

74% of economists in survey see US recession by end of 2021

Aug 20, 2019

WASHINGTON — A strong majority, 74%, of U.S. business economists appear sufficiently concerned about the risks of some of President Donald Trump's economic policies that they expect a recession in the U.S. by the end of 2021. The economists surveyed by the National Association for Business Economics, in a report released Monday, mostly didn't share Trump's optimistic outlook for the economy, though they generally saw recession coming later than they did in a survey taken in February. Thirty-four percent of the economists surveyed said they believe a slowing economy will tip into recession in 2021. That's up from 25% in...

Asian shares rise as investors watch trade war, economies

Aug 20, 2019

TOKYO — Asian shares were higher Monday, as investors continue to rejigger their read on President Donald Trump's trade war and growing worries about slowing economies around the world. Japan's benchmark Nikkei 225 rose 0.6% in early trading to 20,532.95. Australia's S&P/ASX 200 gained 0.8% to 6,454.40, while South Korea's Kospi was 0.4% higher at 1,934.78. Hong Kong's Hang Seng rose 0.9% to 25,734.22. The Shanghai Composite added 0.3% to 2,823.82. On Friday, the S&P 500 rose 41.08 points, or 1.4%, to 2,888.68. The Dow, which had an 800-point drop earlier in the week, added 306.62 points, or 1.2%, to...

Japan's exports fell in July for 8th straight month

Aug 20, 2019

TOKYO — Japan's exports fell for the eighth straight month in July as worries continued about President Donald Trump's trade policies denting Asian economic growth. Ministry of Finance data released Monday showed exports and imports fell in July, compared to the same month a year ago. Exports fell 1.6%, while imports slid 1.2%, resulting in a trade deficit of 249.6 billion yen ($2.35 billion). Global markets have been in turmoil because of Trump's trade war with China. A slowdown in China is certain to hurt other regional economies, including Japan's. Japan's exports to China in July fell 9.3% while its...

Trump wields sanctions hammer; experts wonder to what end

Aug 20, 2019

WASHINGTON — Call it the diplomacy of coercion. The Trump administration is aggressively pursuing economic sanctions as a primary foreign policy tool to an extent unseen in decades, or perhaps ever. Many are questioning the results even as officials insist the penalties are achieving their aims. Since taking office in January 2017, President Donald Trump has used an array of new and existing sanctions against Iran, North Korea and others. His Treasury Department, which oversees economic sanctions, has targeted thousands of entities with asset freezes and business bans. The State Department has been similarly enthusiastic about imposing its own penalties:...

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com